Stay updated on Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoChange DetectedAn NIH funding line, '2018 ( U.S. NIH Grant/Contract )', was added to the funding information section, signaling NIH support for the LEAP-004 trial. This provides background on the source of funding for the study.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedFooter now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This update reflects a page revision and does not affect the study details or user-facing content.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page.SummaryDifference0.0%

- Check63 days agoChange DetectedThe revision label in the study documents section was updated from v3.6.0 to v3.6.3, indicating a newer version of the protocol/document referenced on the page.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page gains new navigation items such as No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, along with a revision tag for v3.6.0. The older heading Intervention / Treatment and the v3.5.5 revision were removed.SummaryDifference0.4%

- Check84 days agoChange DetectedThe page footer now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.